Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-01-10T22:59:23.676Z Has data issue: false hasContentIssue false

Chapter 1 - How Cannabis Works in the Brain

from Part I - Pharmacology of Cannabis and the Endocannabinoid System

Published online by Cambridge University Press:  12 May 2023

By
Michelle Murphy Green  and
Ken Mackie
Edited by
Deepak Cyril D'Souza ,
David Castle  and
Sir Robin Murray
Deepak Cyril D'Souza
Affiliation:
Staff Psychiatrist, VA Connecticut Healthcare System; Professor of Psychiatry, Yale University School of Medicine
David Castle
Affiliation:
University of Tasmania, Australia
Sir Robin Murray
Affiliation:
Honorary Consultant Psychiatrist, Psychosis Service at the South London and Maudsley NHS Trust; Professor of Psychiatric Research at the Institute of Psychiatry
Get access

Summary

Cannabis produces its characteristic intoxicating effect through its actions with specific receptors in the brain. This chapter will explore what we know how about cannabis produces these effects. Since cannabis produces its effects by interacting with the endocannabinoid system, we will start with a brief consideration of the endocannabinoid system relevant to cannabis’ actions. This will be followed by a discussion of the primary psychoactive components of cannabis, their routes of administration, and pharmacokinetics. The next section will focus on how tetrahydrocannabinol interacts with CB1 cannabinoid receptors and how these interactions differ from endocannabinoid interactions with CB1 receptors. Finally, these results will be synthesized in a potential explanation on how cannabis works in the brain.

Keywords

cannabiscannabinoidsendocannabinoid systemcentral nervous systemretrograde signallingsynaptic plasticitypharmacokinetics
Type
Chapter
Information
Marijuana and Madness , pp. 1 - 11
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

de Almeida, D. L., and Devi, L. A. (2020). Diversity of molecular targets and signaling pathways for CBD. Pharmacol Res Perspect, 8, e00682.Google Scholar
Amin, M. R., and Ali, D. W. (2019). Pharmacology of medical cannabis. Adv Exp Med Biol, 1162, 151–165.Google Scholar
Atakan, Z. (2012). Cannabis, a complex plant: Different compounds and different effects on individuals. Ther Adv Psychopharmacol, 2, 241–254.Google Scholar
Atwood, B. K., and Mackie, K. (2010). CB2: A cannabinoid receptor with an identity crisis. Br J Pharmacol, 160, 467–479.CrossRefGoogle ScholarPubMed
Benard, G., Massa, F., Puente, N., et al. (2012). Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat Neurosci, 15, 558–564.CrossRefGoogle ScholarPubMed
Billakota, S., Devinsky, O., and Marsh, E. (2019). Cannabinoid therapy in epilepsy. Curr Opin Neurol, 32, 220–226.CrossRefGoogle ScholarPubMed
Cutando, L., Busquets-Garcia, A., Puighermanal, E., et al. (2013). Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J Clin Invest, 123, 2816–2831.Google Scholar
Da Silva, T., Hafizi, S., Watts, J. J., et al. (2019). In vivo imaging of translocator protein in long-term cannabis users. JAMA Psychiatry, 76, 1305–1313.CrossRefGoogle ScholarPubMed
Diana, M. A., and Marty, A. (2004). Endocannabinoid-mediated short-term synaptic plasticity: Depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol, 142, 9–19.Google Scholar
Dujourdy, L., and Besacier, F. (2017). A study of cannabis potency in France over a 25 years period (1992–2016). Forensic Sci Int, 272, 72–80.Google Scholar
Egertova, M., and Elphick, M. R. (2000) Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J Comp Neurol, 422, 159–171.Google Scholar
ElSohly, M. A., Mehmedic, Z., Foster, S., et al. (2016). Changes in cannabis potency over the last 2 decades (1995–2014): Analysis of current data in the United States. Biol Psychiatry, 79, 613–619.CrossRefGoogle ScholarPubMed
Farrell, J. S., Colangeli, R., Dong, A., et al. (2021). In vivo endocannabinoid dynamics at the timescale of physiological and pathological neural activity. Neuron, 109, 2398–2403 e4.Google Scholar
Gaoni, Y., and Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc, 86, 1646–1647.Google Scholar
Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet, 42, 327–360.CrossRefGoogle ScholarPubMed
Gulck, T., and Moller, B. L. (2020). Phytocannabinoids: Origins and biosynthesis. Trends Plant Sci, 25, 985–1004.CrossRefGoogle ScholarPubMed
Han, J., Kesner, P., Metna-Laurent, M., et al. (2012). Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell, 148, 1039–1050.CrossRefGoogle ScholarPubMed
Herkenham, M., Lynn, A. B., Johnson, M. R., et al. (1991). Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci, 11, 563–583.CrossRefGoogle Scholar
Howlett, A. C., Barth, F., Bonner, T. I., et al. (2002). International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev, 54, 161–202.Google Scholar
Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chem Biodivers, 4, 1770–1804.CrossRefGoogle ScholarPubMed
Huestis, M. A., Boyd, S. J., Heishman, S. J., et al. (2007). Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology (Berl), 194, 505–515.Google Scholar
Huestis, M. A., Gorelick, D. A., Heishman, S. J., et al. (2001). Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry, 58, 322–328.CrossRefGoogle ScholarPubMed
Itami, C., Huang, J. Y., Yamasaki, M., et al. (2016). Developmental switch in spike timing-dependent plasticity and cannabinoid-dependent reorganization of the thalamocortical projection in the barrel cortex. J Neurosci, 36, 7039–7054.Google Scholar
Kenakin, T. (2019). Emergent concepts of receptor pharmacology. Handb Exp Pharmacol, 260, 17–41.CrossRefGoogle ScholarPubMed
Laaris, N., Good, C. H., and Lupica, C. R. (2010). Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. Neuropharmacology, 59, 121–127.Google Scholar
Laprairie, R. B., Bagher, A. M., Kelly, M. E., et al. (2015). Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol, 172, 4790–4805.CrossRefGoogle ScholarPubMed
Lu, H. C., and Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biol Psychiatry, 79, 516–525.CrossRefGoogle Scholar
Lucas, C. J., Galettis, P., and Schneider, J. (2018). The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol, 84, 2477–2482.Google Scholar
Mackie, K. (2008). Signaling via CNS cannabinoid receptors. Mol Cell Endocrinol, 286, S60–S65.CrossRefGoogle ScholarPubMed
Marinelli, S., Pacioni, S., Bisogno, T., et al. (2008). The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self- inhibition in neocortical interneurons. J Neurosci, 28, 13532–13541.CrossRefGoogle ScholarPubMed
Marsicano, G., and Lutz, B. (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci, 11, 4213–4225.Google Scholar
Matsuda, L. A., Bonner, T. I., and Lolait, S. J. (1993). Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol, 327, 535–550.Google Scholar
McPartland, J. M., Duncan, M., Di Marzo, V., et al. (2015). Are cannabidiol and Delta(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol, 172, 737–753.Google Scholar
Mechoulam, R., and Shvo, Y. (1963). Hashish. I. The structure of cannabidiol. Tetrahedron, 19, 2073–2078.Google Scholar
Millar, S. A., Stone, N. L., Yates, A. S., et al. (2018). A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol, 9, 1365.Google Scholar
Nadulski, T., Pragst, F., Weinberg, G., et al. (2005). Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Ther Drug Monit, 27, 799–810.Google Scholar
O’Sullivan, S. E., Stevenson, C. W., and Laviolette, S. R. (2021) Could cannabidiol be a treatment for coronavirus disease-19-related anxiety disorders? Cannabis Cannabinoid Res, 6, 7–18.Google Scholar
Sharma, P., Murthy, P., and Bharath, M. M. (2012). Chemistry, metabolism, and toxicology of cannabis: Clinical implications. Iran J Psychiatry, 7, 149–156.Google ScholarPubMed
Spindle, T. R., Cone, E. J., Goffi, E., et al. (2020). Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Drug Alcohol Depend, 211, 107937.Google Scholar
Straiker, A., Dvorakova, M., Zimmowitch, A., et al. (2018). Cannabidiol inhibits endocannabinoid signaling in autaptic hippocampal neurons. Mol Pharmacol, 94, 743–748.CrossRefGoogle ScholarPubMed
Straiker, A., and Mackie, K. (2005). Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol, 569, 501–517.CrossRefGoogle ScholarPubMed
Tahir, M. N., Shahbazi, F., Rondeau-Gagne, S., et al. (2021). The biosynthesis of the cannabinoids. J Cannabis Res, 3, 7.Google Scholar
Tsou, K., Brown, S., Sanudo-Pena, M. C., et al. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393–411.Google Scholar
Turner, S. E., Williams, C. M., Iversen, L., et al. (2017). Molecular pharmacology of phytocannabinoids. Prog Chem Org Nat Prod, 103, 61–101.Google Scholar
Zamberletti, E., Gabaglio, M., Prini, P., et al. (2015). Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats. Eur Neuropsychopharmacol, 25, 2404–2415.CrossRefGoogle ScholarPubMed
Zou, S., and Kumar, U. (2018). Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. Int J Mol Sci, 19, 833.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • How Cannabis Works in the Brain
  • Edited by Deepak Cyril D'Souza, Staff Psychiatrist, VA Connecticut Healthcare System; Professor of Psychiatry, Yale University School of Medicine, David Castle, University of Tasmania, Australia, Sir Robin Murray, Honorary Consultant Psychiatrist, Psychosis Service at the South London and Maudsley NHS Trust; Professor of Psychiatric Research at the Institute of Psychiatry
  • Book: Marijuana and Madness
  • Online publication: 12 May 2023
  • Chapter DOI: https://doi.org/10.1017/9781108943246.002
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • How Cannabis Works in the Brain
  • Edited by Deepak Cyril D'Souza, Staff Psychiatrist, VA Connecticut Healthcare System; Professor of Psychiatry, Yale University School of Medicine, David Castle, University of Tasmania, Australia, Sir Robin Murray, Honorary Consultant Psychiatrist, Psychosis Service at the South London and Maudsley NHS Trust; Professor of Psychiatric Research at the Institute of Psychiatry
  • Book: Marijuana and Madness
  • Online publication: 12 May 2023
  • Chapter DOI: https://doi.org/10.1017/9781108943246.002
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • How Cannabis Works in the Brain
  • Edited by Deepak Cyril D'Souza, Staff Psychiatrist, VA Connecticut Healthcare System; Professor of Psychiatry, Yale University School of Medicine, David Castle, University of Tasmania, Australia, Sir Robin Murray, Honorary Consultant Psychiatrist, Psychosis Service at the South London and Maudsley NHS Trust; Professor of Psychiatric Research at the Institute of Psychiatry
  • Book: Marijuana and Madness
  • Online publication: 12 May 2023
  • Chapter DOI: https://doi.org/10.1017/9781108943246.002
Available formats
×